Parenterally administered D ‐amphetamine has been used as a challenge drug to release dopamine, which in turns inhibits [ 11 C]raclopride binding to dopaminergic D 2 receptors as measured using positron emission tomography (PET) techniques. The primary objective of this study was to determine whe…